[go: up one dir, main page]

EA201890331A1 - Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена - Google Patents

Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена

Info

Publication number
EA201890331A1
EA201890331A1 EA201890331A EA201890331A EA201890331A1 EA 201890331 A1 EA201890331 A1 EA 201890331A1 EA 201890331 A EA201890331 A EA 201890331A EA 201890331 A EA201890331 A EA 201890331A EA 201890331 A1 EA201890331 A1 EA 201890331A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyridinodicarboxamides
bromodoum
inhibitors
application
compounds
Prior art date
Application number
EA201890331A
Other languages
English (en)
Other versions
EA033679B1 (ru
Inventor
Стивен Джон Аткинсон
Хелен Элизабет Эйлотт
Энтони Уилльям Джеймс Купер
Эммануэль Юбер Демон
Ли Эндрю Харрисон
Томас Джордж Кристофер Хэйхау
Мэттью Дж. Линдон
Александер Дж. Престон
Джонатан Томас Сиал
Иан Дэвид Уолл
Роберт Дж. Ватсон
Джеймс Майкл Вулвен
Original Assignee
Глаксосмитклайн Интеллекчуал Проперти (№ 2) Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глаксосмитклайн Интеллекчуал Проперти (№ 2) Лимитед filed Critical Глаксосмитклайн Интеллекчуал Проперти (№ 2) Лимитед
Publication of EA201890331A1 publication Critical patent/EA201890331A1/ru
Publication of EA033679B1 publication Critical patent/EA033679B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к соединениям формулы (I) и их солям, фармацевтическим композициям, содержащим такие соединения, и к их применению в терапии
EA201890331A 2015-09-02 2016-08-31 Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена EA033679B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562213137P 2015-09-02 2015-09-02
PCT/EP2016/070519 WO2017037116A1 (en) 2015-09-02 2016-08-31 Pyridinone dicarboxamide for use as bromodomain inhibitors

Publications (2)

Publication Number Publication Date
EA201890331A1 true EA201890331A1 (ru) 2018-08-31
EA033679B1 EA033679B1 (ru) 2019-11-15

Family

ID=56943472

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201890331A EA033679B1 (ru) 2015-09-02 2016-08-31 Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена

Country Status (22)

Country Link
US (2) US10428026B2 (ru)
EP (1) EP3344615A1 (ru)
JP (1) JP6532599B2 (ru)
KR (1) KR102088157B1 (ru)
CN (1) CN108137542B (ru)
AR (1) AR105875A1 (ru)
AU (1) AU2016315360B2 (ru)
CA (1) CA2996245C (ru)
CL (1) CL2018000565A1 (ru)
CO (1) CO2018002211A2 (ru)
CR (1) CR20180138A (ru)
DO (1) DOP2018000062A (ru)
EA (1) EA033679B1 (ru)
HK (1) HK1249504A1 (ru)
IL (1) IL257431B (ru)
MA (1) MA43940A (ru)
MX (1) MX384798B (ru)
PE (1) PE20181273A1 (ru)
PH (1) PH12018500446A1 (ru)
TW (1) TWI724022B (ru)
UY (1) UY36875A (ru)
WO (1) WO2017037116A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA033679B1 (ru) * 2015-09-02 2019-11-15 Glaxosmithkline Ip No 2 Ltd Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена
EP3353162A1 (en) 2015-09-22 2018-08-01 Glaxosmithkline Intellectual Property (No. 2) Limited Pyridinone dicarboxamide for use as bromodomain inhibitors
US10471050B2 (en) 2015-10-05 2019-11-12 Glaxosmithkline Intellectual Property (No.2) Limited 2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors
JP6954921B2 (ja) 2016-04-07 2021-10-27 グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ ブロモドメイン阻害薬としてのピリジル誘導体
AU2017269673A1 (en) * 2016-05-24 2018-11-22 Glaxosmithkline Intellectual Property (No.2) Limited Pyridine dicarboxamide derivatives as bromodomain inhibitors
JOP20190192A1 (ar) 2017-03-01 2019-08-08 Glaxosmithkline Ip No 2 Ltd مشتقات بيرازول بوصفها مثبطات برومودومين
GB201703282D0 (en) 2017-03-01 2017-04-12 Glaxosmithkline Intellectual Property (No 2) Ltd Compounds
CN108003085A (zh) * 2017-12-19 2018-05-08 张开良 一种药物中间体芳甲酰基吲哚衍生物的合成方法
CN108484494B (zh) * 2018-06-15 2021-07-30 沈阳药科大学 2-氧代-1,2-二氢吡啶-4-甲酸类化合物
GB201814167D0 (en) 2018-08-31 2018-10-17 Glaxosmithkline Ip No 2 Ltd Compounds
KR20230026461A (ko) 2020-06-23 2023-02-24 제넨테크, 인크. 거대고리 화합물 및 이의 사용 방법

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1357111B1 (en) * 2000-12-28 2009-08-05 Shionogi & Co., Ltd. 2-pyridone derivatives having affinity for cannabinoid type 2 receptor
JPWO2003070277A1 (ja) 2002-02-19 2005-06-09 塩野義製薬株式会社 抗掻痒剤
EP1551824B1 (en) 2002-10-09 2007-12-12 Critical Outcome Technologies, Inc. Protein tyrosine kinase inhibitors
MXPA05005360A (es) 2002-11-18 2005-08-03 Schering Corp Inhibidores de 17beta-hidroxiesteroide deshidrogenasa de tipo 3 para el tratamiento de enfermedades que dependen de androgenos.
EP1433788A1 (en) 2002-12-23 2004-06-30 Aventis Pharma Deutschland GmbH Pyrazole-derivatives as factor Xa inhibitors
SE0302487D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
TW200700392A (en) 2005-03-16 2007-01-01 Astrazeneca Ab Novel compounds
TW200808763A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds I
CA2704714C (en) * 2007-11-15 2018-12-04 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Pyridazinone derivatives as parp inhibitors
WO2009158315A1 (en) * 2008-06-25 2009-12-30 Smithkline Beecham Corporation Prolyl hydroxylase inhibitors
GB0919434D0 (en) 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
UA111756C2 (uk) 2011-11-03 2016-06-10 Ф. Хоффманн-Ля Рош Аг Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
HK1208681A1 (en) * 2012-06-12 2016-03-11 Abbvie Inc. Pyridinone and pyridazinone derivatives
CN104781254B (zh) 2012-11-08 2016-12-14 百时美施贵宝公司 可作为激酶调节剂的经杂芳基取代的吡啶基化合物
WO2014096965A2 (en) 2012-12-21 2014-06-26 Rvx Therapeutics Inc. Novel heterocyclic compounds as bromodomain inhibitors
US9855271B2 (en) 2013-07-31 2018-01-02 Zenith Epigenetics Ltd. Quinazolinones as bromodomain inhibitors
DE102013215912B3 (de) * 2013-08-12 2015-02-26 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Farbneutral beschichteter kupferhaltiger Gegenstand, Verfahren zu dessen Herstellung sowie Verwendung einer entsprechenden farbneutralen Beschichtung
CN105939996A (zh) 2013-12-09 2016-09-14 艾伯维公司 用作布罗莫结构域抑制剂的二氢吡啶酮和二氢哒嗪酮衍生物
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
EA033679B1 (ru) 2015-09-02 2019-11-15 Glaxosmithkline Ip No 2 Ltd Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена
US10471050B2 (en) 2015-10-05 2019-11-12 Glaxosmithkline Intellectual Property (No.2) Limited 2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors
JP6954921B2 (ja) 2016-04-07 2021-10-27 グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ ブロモドメイン阻害薬としてのピリジル誘導体
AU2017269673A1 (en) 2016-05-24 2018-11-22 Glaxosmithkline Intellectual Property (No.2) Limited Pyridine dicarboxamide derivatives as bromodomain inhibitors

Also Published As

Publication number Publication date
CA2996245C (en) 2023-10-17
KR102088157B1 (ko) 2020-03-12
KR20180043366A (ko) 2018-04-27
UY36875A (es) 2017-03-31
DOP2018000062A (es) 2018-03-30
AU2016315360B2 (en) 2019-09-12
CR20180138A (es) 2018-07-16
IL257431A (en) 2018-04-30
AU2016315360A1 (en) 2018-03-22
TW201718504A (zh) 2017-06-01
IL257431B (en) 2021-04-29
US10927080B2 (en) 2021-02-23
HK1249504A1 (zh) 2018-11-02
US20180258044A1 (en) 2018-09-13
PH12018500446A1 (en) 2018-09-10
JP2018526383A (ja) 2018-09-13
CL2018000565A1 (es) 2018-07-06
WO2017037116A1 (en) 2017-03-09
CN108137542A (zh) 2018-06-08
EA033679B1 (ru) 2019-11-15
BR112018003827A2 (pt) 2018-09-25
MA43940A (fr) 2018-12-12
JP6532599B2 (ja) 2019-06-19
EP3344615A1 (en) 2018-07-11
TWI724022B (zh) 2021-04-11
MX384798B (es) 2025-03-14
CO2018002211A2 (es) 2018-05-21
US20190359572A1 (en) 2019-11-28
AR105875A1 (es) 2017-11-15
CA2996245A1 (en) 2017-03-09
PE20181273A1 (es) 2018-08-03
US10428026B2 (en) 2019-10-01
MX2018002699A (es) 2018-04-13
CN108137542B (zh) 2023-10-27

Similar Documents

Publication Publication Date Title
EA201890331A1 (ru) Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена
EA201690598A1 (ru) Аминогетероарил бензамиды в качестве ингибиторов киназы
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201592068A1 (ru) Ингибиторы энхансера zeste гомолога 2
MX389349B (es) Derivados de ácido borónico y usos terapéuticos de los mismos.
EA201792205A1 (ru) Гетероциклические соединения как ингибиторы lsd1
EA201891063A1 (ru) Производные дигидроимидазопиразинона, применимые в лечении рака
MD4650B1 (ru) Производные хиназолина, используемые при лечении ВИЧ
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
BR112017013440A2 (pt) compostos de isoquinolina para o tratamento de hiv
EA201591727A1 (ru) Соединения биариламида в качестве ингибиторов киназы
EA201391285A1 (ru) Производные тетрагидрохинолина, полезные в качестве ингибиторов бромодомена
EA201500926A1 (ru) Фумараты как пролекарства и их применение при лечении различных заболеваний
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EA201790599A1 (ru) Соединения и композиции в качестве ингибиторов киназ
EA201692480A1 (ru) Фармацевтическая композиция
MX382624B (es) Compuestos farmacéuticos.
CY1122313T1 (el) Ορβεπιταντη για την αγωγη του χρονιου κνησμου
EA201891379A1 (ru) Ингибиторы тирозинкиназы брутона и способы их применения
EA201692548A1 (ru) Минеральные аминокислотные комплексы активных веществ
EA201590787A1 (ru) Замещенные пиридопиразины в качестве ингибиторов syk
EA201792057A1 (ru) Конденсированные бициклические гетероарильные производные с активностью ингибиторов пролилгидроксилазы
EA201790570A1 (ru) Модуляторы р2х7
EA201792425A1 (ru) Трициклические соединения и их применение в качестве ингибиторов фосфодиэстераз
AU2017269673A1 (en) Pyridine dicarboxamide derivatives as bromodomain inhibitors

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM